Motor-Sparing Femoral Nerve Block Dose

NCT02909257 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

31

Enrollment

OTHER

Sponsor class

Stopped inadequate methodology to determine primary outcome

Conditions

Osteoarthritis, Knee
Knee Injuries

Interventions

DRUG: Same Bupivacaine Concentration
DRUG: Lower Bupivacaine Concentration

Sponsor

University of Chile